Baldwin Brothers LLC Laboratory Corp Of America Holdings Transaction History

Baldwin Brothers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$209.01 - $232.56 $12,540 - $13,953	-60 Reduced 75.0%	20 $4,000
Q4 2023 Jan 08, 2024	BUY	$197.69 - $227.29 $11,861 - $13,637	60 Added 300.0%	80 $18,000
Q1 2023 Apr 21, 2023	BUY	$213.32 - $257.83 $3,199 - $3,867	15 Added 300.0%	20 $4,000
Q3 2022 Oct 14, 2022	BUY	$204.81 - $262.19 $1,024 - $1,310	5 New	5 $1,000
Q3 2020 Oct 16, 2020	SELL	$167.03 - $201.3 $4,175 - $5,032	-25 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$149.47 - $160.56 $3,736 - $4,014	25	25 $4,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Brothers LLC with notifications on news.